Published in Leukemia on November 13, 2008
Macrophage IL-10 blocks CD8+ T cell-dependent responses to chemotherapy by suppressing IL-12 expression in intratumoral dendritic cells. Cancer Cell (2014) 2.00
The transcription factor MITF is a critical regulator of GPNMB expression in dendritic cells. Cell Commun Signal (2015) 1.46
Negative regulation of MyD88-dependent signaling by IL-10 in dendritic cells. Proc Natl Acad Sci U S A (2009) 1.26
Negative regulation of Toll-like receptor 4 signaling by IL-10-dependent microRNA-146b. Proc Natl Acad Sci U S A (2013) 1.25
Patent filarial infection modulates malaria-specific type 1 cytokine responses in an IL-10-dependent manner in a filaria/malaria-coinfected population. J Immunol (2009) 1.21
Costimulatory molecules on immunogenic versus tolerogenic human dendritic cells. Front Immunol (2013) 1.02
IFN-beta inhibits dendritic cell migration through STAT-1-mediated transcriptional suppression of CCR7 and matrix metalloproteinase 9. J Immunol (2010) 0.98
CD19(+) B cells confer protection against experimental cerebral malaria in semi-immune rodent model. PLoS One (2013) 0.81
Targeting dendritic cell function during systemic autoimmunity to restore tolerance. Int J Mol Sci (2014) 0.80
Generation and functional characterization of MDSC-like cells. Oncoimmunology (2017) 0.75
Retracted Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids. Nat Med (2000) 2.64
Proteasome inhibitors: antitumor effects and beyond. Leukemia (2006) 1.87
Monocyte-derived dendritic cells are permissive to the complete replicative cycle of human cytomegalovirus. J Gen Virol (2000) 1.60
The epithelial tumor antigen MUC1 is expressed in hematological malignancies and is recognized by MUC1-specific cytotoxic T-lymphocytes. Cancer Res (2001) 1.50
Intensive chemotherapeutic regimens against acute leukemia transiently suppress asthma symptoms but do not lead to long-term relief. Pediatr Hematol Oncol (2000) 1.39
An even closer look at therapeutic touch. JAMA (1998) 1.38
Determinants of survival in patients with brain metastases from cutaneous melanoma. Br J Cancer (2010) 1.37
Acute and long-lasting changes in extracellular-matrix chondroitin-sulphate proteoglycans induced by injection of chondroitinase ABC in the adult rat brain. Exp Brain Res (1998) 1.13
Tandem-pore domain potassium channels are functionally expressed in retinal (Müller) glial cells. Glia (2006) 1.08
Expression of vascular endothelial growth factor (VEGF) and its receptors in human neuroblastoma. Eur J Cancer (1999) 1.06
P2 receptors in satellite glial cells in trigeminal ganglia of mice. Neuroscience (2003) 1.02
Immunomodulatory effects of anti-angiogenic drugs. Leukemia (2011) 1.02
Dendritic cell-based cancer immunotherapy targeting MUC-1. Cancer Immunol Immunother (2005) 1.01
A phase I/II study of bortezomib and capecitabine in patients with metastatic breast cancer previously treated with taxanes and/or anthracyclines. Ann Oncol (2008) 1.01
Rituximab consolidation after high-dose chemotherapy and autologous blood stem cell transplantation in follicular and mantle cell lymphoma: a prospective, multicenter phase II study. Ann Oncol (2004) 1.00
Expression of MUC-1 epitopes on normal bone marrow: implications for the detection of micrometastatic tumor cells. J Clin Oncol (1999) 0.98
Tumor necrosis factor alpha and CD40 ligand antagonize the inhibitory effects of interleukin 10 on T-cell stimulatory capacity of dendritic cells. Cancer Res (2000) 0.98
Clinical studies applying cytokine-induced killer cells for the treatment of renal cell carcinoma. Clin Dev Immunol (2012) 0.98
Status of stroke patients: a community assessment. Arch Phys Med Rehabil (1986) 0.96
Baseline non-fasting serum leptin concentration to body mass index ratio is predictive of IVF outcomes. Hum Reprod (2001) 0.94
Electrophysiology of rabbit Müller (glial) cells in experimental retinal detachment and PVR. Invest Ophthalmol Vis Sci (2001) 0.94
Spatial distribution of spermine/spermidine content and K(+)-current rectification in frog retinal glial (Müller) cells. Glia (2000) 0.91
Immune regulatory loops determine productive interactions within human T lymphocyte-dendritic cell clusters. Proc Natl Acad Sci U S A (1999) 0.91
T-cell receptor beta variable region diversity in melanoma metastases after interleukin 2-based immunotherapy. Clin Cancer Res (1996) 0.90
Delivery of tumor-derived RNA for the induction of cytotoxic T-lymphocytes. Gene Ther (2003) 0.89
Quality of well being in patients with fibromyalgia. J Rheumatol (2000) 0.89
Symptom management in older primary care patients: feasibility of an experimental, written self-disclosure protocol. Ann Intern Med (2001) 0.89
Successful treatment of multicentric Castleman's disease with combined immunochemotherapy in an AIDS patient with multiorgan failure. Leukemia (2008) 0.88
Direct identification of major histocompatibility complex class I-bound tumor-associated peptide antigens of a renal carcinoma cell line by a novel mass spectrometric method. Cancer Res (1998) 0.87
Treatment with lenalidomide induces immunoactivating and counter-regulatory immunosuppressive changes in myeloma patients. Clin Exp Immunol (2014) 0.86
Spermine/spermidine is expressed by retinal glial (Müller) cells and controls distinct K+ channels of their membrane. Glia (1998) 0.84
In vivo and in vitro labelling of perineuronal nets in rat brain. Brain Res (1996) 0.84
Detection of a new JAK2 D620E mutation in addition to V617F in a patient with polycythemia vera. Leukemia (2006) 0.84
Quality assurance in RT-PCR-based BCR/ABL diagnostics--results of an interlaboratory test and a standardization approach. Leukemia (2000) 0.83
Ex vivo generation of human cytomegalovirus-specific cytotoxic T cells by peptide-pulsed dendritic cells. Br J Haematol (2001) 0.82
Proteasome inhibition overcomes the resistance of renal cell carcinoma cells against the PPARgamma ligand troglitazone. Cell Mol Life Sci (2009) 0.82
Kir subfamily in frog retina: specific spatial distribution of Kir 6.1 in glial (Müller) cells. Neuroreport (2001) 0.82
Activation of voltage-gated Na⁺ and Ca²⁺ channels is required for glutamate release from retinal glial cells implicated in cell volume regulation. Neuroscience (2011) 0.82
RUNX1 mutations in acute myeloid leukemia are associated with distinct clinico-pathologic and genetic features. Leukemia (2016) 0.81
The Müller (glial) cell in normal and diseased retina: a case for single-cell electrophysiology. Ophthalmic Res (1997) 0.81
Dendritic cell-based vaccines in patients with hematological malignancies. Ann N Y Acad Sci (2001) 0.80
Experimental dispase-induced retinopathy causes up-regulation of P2Y receptor-mediated calcium responses in Müller glial cells. Ophthalmic Res (2003) 0.80
Involvement of calcium-activated potassium channels in the regulation of DNA synthesis in cultured Müller glial cells. Invest Ophthalmol Vis Sci (2000) 0.80
Characterization of BAX inhibitor-1 as a novel leukemia-associated antigen. Leukemia (2009) 0.80
Erythropoietin inhibits osmotic swelling of retinal glial cells by Janus kinase- and extracellular signal-regulated kinases1/2-mediated release of vascular endothelial growth factor. Neuroscience (2009) 0.80
Anticancer vaccination strategies. Ann Oncol (2004) 0.80
Osteopontin inhibits osmotic swelling of retinal glial (Müller) cells by inducing release of VEGF. Neuroscience (2013) 0.80
Zoledronic acid inhibits the function of Toll-like receptor 4 ligand activated monocyte-derived dendritic cells. Leukemia (2007) 0.80
Comparison of CT during arterial portography and MR during arterial portography in the detection of liver metastases. AJR Am J Roentgenol (2006) 0.79
Long-term engraftment of systemically transplanted, gene-modified bone marrow-derived cells in the adult mouse retina. Br J Ophthalmol (2008) 0.79
Approaches to dendritic cell-based immunotherapy after peripheral blood stem cell transplantation. Ann N Y Acad Sci (1999) 0.77
Development of novel compounds to treat autoimmune and inflammatory diseases and graft versus host reactions. Endocr Metab Immune Disord Drug Targets (2007) 0.77
Direct effects of protirelin (TRH) on cultured porcine thyrocytes. J Endocrinol Invest (1992) 0.77
Immunomodulatory effects of ultra-low-dose interleukin-2 in cancer patients: a phase-IB study. Cancer Immunol Immunother (1993) 0.77
Serum cytokine levels in cancer patients treated with different schedules of ultra-low-dose interleukin-2. J Immunother Emphasis Tumor Immunol (1994) 0.77
[Proliferative vitreoretinopathy--pathogenesis and therapy]. Klin Monbl Augenheilkd (2010) 0.77
Restriction of T cell receptor V beta repertoire in melanoma metastasis responding to immunotherapy. Melanoma Res (1995) 0.76
New perspectives in dendritic cell-based cancer immunotherapy. BioDrugs (2001) 0.76
Nucleus basalis magnocellularis and pedunculopontine tegmental nucleus: control of the slow EEG waves in rats. Arch Ital Biol (1996) 0.76
Induction of minor histocompatiblity antigen HA-1-specific cytotoxic T cells for the treatment of leukemia after allogeneic stem cell transplantation. Blood (1999) 0.76
Tigecycline in febrile neutropenic patients with haematological malignancies: a retrospective case documentation in four university hospitals. Infection (2013) 0.76
Pion electromagnetic form factor at spacelike momenta. Phys Rev Lett (2013) 0.75
Nucleus cuneiformis lesion increases high-voltage spindle incidence in unrestrained rat neocortex. Arch Ital Biol (1994) 0.75
Using a student-run community agency for clinical experience. Nurse Educ (1977) 0.75
Sporotrichoid cutaneous leishmaniasis in a traveler. South Med J (1997) 0.75
Pion distribution amplitude from lattice QCD. Phys Rev Lett (2013) 0.75
[Listeria monocytogenes rhombencephalitis: clinical and pathologic-anatomic findings in a rare encephalitis form]. Nervenarzt (1982) 0.75
Interleukin-2-based immunotherapy and chemoimmunotherapy in metastatic melanoma. Recent Results Cancer Res (1995) 0.75
Pair production and optical lasers. Phys Rev Lett (2006) 0.75
Addition of dacarbazine or cisplatin to interferon-alpha/interleukin-2 in metastatic melanoma: toxicity and immunological effects. Melanoma Res (1995) 0.75
Pair creation and an x-ray free electron laser. Phys Rev Lett (2001) 0.75
Imaging dynamical chiral-symmetry breaking: pion wave function on the light front. Phys Rev Lett (2013) 0.75
Pharmacy residency training programs: a resident's perspective. Pharm Pract Manag Q (1995) 0.75
Goal-directed temporal plans of care. Nurs Manage (1992) 0.75
Quantum effects with an x-ray free-electron laser. Phys Rev Lett (2002) 0.75
Effects of retinoids on porcine thyrocytes under different culture conditions. Histochem J (2001) 0.75
Ex vivo expansion of normal progenitor cells from acute myeloid leukemia cell-contaminated CD34+ peripheral blood progenitor cells after mafosfamide purging. J Hematother Stem Cell Res (2001) 0.75
Protein kinases A and C are opponents in modulating glial Ca2+ -activated K+ channels. Neuroreport (1999) 0.75